Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2019 Jun 12;25(10):2024–2030. doi: 10.1016/j.bbmt.2019.06.004

Table 1.

Patient and Transplant Characteristics

Patient characteristics N (%)
Number of patients 5022
Number of centers 183
Age, median (range), years 8 (<1-21)
Age group (years, y)
 <1 623 (12)
 1-<2 382 (8)
 2-<5 816 (16)
 5-<10 1183 (24)
 10-<21 2018 (40)
Indication for transplant
 Malignancies
  AML/MDS 1248 (25)
  ALL 949 (19)
  Other leukemia 128 (3)
  Lymphomas 117 (2)
  Other malignancies 10 (<1)
 Non-malignant diseases
  Aplastic Anemia 449 (9)
  Erythrocyte disorders 869 (17)
  SCID & other immune deficiencies 752 (15)
  Metabolic diseases 295 (6)
  Histiocytic disorders 171 (3)
  Other non-malignantα 34 (<1)
Conditioning intensity
  MAC 3552 (71)
  RIC 579 (11)
  NMA 566 (11)
  No conditioning (non-malignant only) 209 (4)
  Missing 118 (2)
TBI used in conditioning
  Yes 1662 (33)
  No 3246 (65)
  Missing 114 (2)
Donor type
  HLA-identical sibling 973 (19)
  Other related 662 (13)
  Well-matched unrelated 860 (17)
  Partially-matched unrelated (partial and mis-matched) 353 (7)
  Unrelated match unknown 83 (2)
  Cord blood 2089 (42)
  Missing 2 (<1)
Graft type
  Bone marrow 2070 (41)
  Peripheral blood 863 (17)
  Umbilical cord blood 2089 (42)
Donor/recipient CMV serostatus
  +/+ 1171 (23)
  +/− 384 (8)
  −/+ 655 (13)
  −/− 614 (12)
  CB - recipient + 1128 (22)
  CB - recipient − 909 (18)
  CB - recipient CMV unknown 52 (1)
  Missing 109 (2)
Pulmonary comorbidity
  No pulmonary disease 4436 (88)
  Moderate pulmonary disease 308 (6)
  Patient characteristics N (%)
  Severe pulmonary disease 217 (4)
  Missing 61 (1)
Median follow-up of survivors (range), months 31 (1-96)
α

Other non-malignant: Platelet disorder: n=24, autoimmune disorder: n=10